Last reviewed · How we verify

target drug with the score above 0,1

OmicsWay Corp. · Phase 2 active Small molecule

target drug with the score above 0,1 is a Small molecule drug developed by OmicsWay Corp.. It is currently in Phase 2 development.

At a glance

Generic nametarget drug with the score above 0,1
SponsorOmicsWay Corp.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about target drug with the score above 0,1

What is target drug with the score above 0,1?

target drug with the score above 0,1 is a Small molecule drug developed by OmicsWay Corp..

Who makes target drug with the score above 0,1?

target drug with the score above 0,1 is developed by OmicsWay Corp. (see full OmicsWay Corp. pipeline at /company/omicsway-corp).

What development phase is target drug with the score above 0,1 in?

target drug with the score above 0,1 is in Phase 2.

Related